Gerresheimer to double plastics turnover with Superfos acquisition

By Kirsty Barnes

- Last updated on GMT

Related tags Pharmaceutical drug Pharmacy Plastic

Superfos Pharma, one of Europe's leading suppliers of plastic
packaging for the pharma market, has been acquired by Gerresheimer
in a move that should double the group's turnover in plastics to
€50 million.

The acquisition, now completed, fits in with the latest activities of >Gerresheimer​ towards worldwide expansion of its business in pharmaceutics packaging and systems.

>Gerresheimer​ Superfos Pharma provides an ideal fit with the plastic operations of the Gerresheimer subsidiaries Bünder Glas and Polfa, which are presently being integrated in a strong group.

"We are currently experiencing a very dynamic phase of group development. The present acquisition marks another important step on our way to become a leading worldwide supplier of pharmaceutical packaging,"​ said CEO and president of Gerresheimer, Dr. Axel Herberg.

The German manufacturer also took over pharmaceutical businesses in the USA and China in October this year.

"We are expanding our technological base and creating new growth opportunities. Through these two acquisitions we increased our pharmaceutical sales by more than €70 million in just a few months and at the same time established an important position in East Asia,"​ said Herberg.

After the acquisition of Danish company Superfos Pharma, Gerresheimer will manufacture its products in 21 locations throughout Europe, America and Asia.

Following the sale Superfos Pharma, the Superfos Group said it will now concentrate on its injection moulded plastic packaging business, strengthening it in Europe and the USA.

"We are very pleased that we have found a buyer that with a strong platform as one of the leading suppliers of glass on the pharmaceutical market provides the right conditions and the opportunity to expand Superfos Pharma's very large international growth potential for plastic packaging for pharmaceuticals,"​ said Superfos CEO Kim Andersen.

Related topics Drug Delivery

Related news

Show more

Follow us


View more